Pfizer, BioNTech Final Analysis Says COVID-19 Vaccine Has 95% Efficacy

In a final analysis released by Pfizer and BioNTech, coronavirus vaccine had a 95% efficacy rate. The report says the vaccine was well tolerated and no serious safety concerns were observed.